The Economic Times - Healthcare / Biotech
-
Sun basks in improved US sales
Fetched: January 31st, 2008, 11:51pm EST
Tags: [edit]
Sun Pharmaceuticals registered a spectacular performance during the December 2007 quarter -
Sun Pharma launches generic Protonix tablets
Fetched: January 31st, 2008, 11:51pm EST
Tags: [edit]
Sun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is AB-rated to Wyeth's Protonix DR Tablets. -
Pharma summit to showcase R&D potential
Fetched: January 31st, 2008, 11:51pm EST
Tags: [edit]
With the Indian pharmaceutical industry making rapid strides in the last few years, many observers are betting on the country becoming an attractive destination for research and development in the near future. -
Ranbaxy, DRL, Lupin in race for 53% stake in Romanian pharma co
Fetched: January 29th, 2008, 11:07pm EST
Tags: [edit]
Ranbaxy Laboratories, Dr Reddy’s Laboratories (DRL) and Lupin are learnt to be in the fray to acquire 53% stake in Romania’s leading pharmaceutical company Antibiotice. -
Glenmark Pharmaceuticals gets FDA nod for Baddi plant in HP
Fetched: January 28th, 2008, 9:33pm EST
Tags: [edit]
Glenmark Pharmaceuticals on Monday said it has received the US Food and Drug Administration's approval for its semi solid dosage manufacturing plant at Baddi in HP. -
Breather for Novartis on blood patent row, SC stays High Court order
Fetched: January 28th, 2008, 9:33pm EST
Tags: [edit]
The Supreme Court on Monday stayed the recent Madras High Court order that had ruled that the Intellectual Property Appellate Board can hear Novartis’ patent rejection appeal without a technical committee. -
Glaxo launches new Horlicks for women
Fetched: January 28th, 2008, 9:33pm EST
Tags: [edit]
Healthcare products maker GlaxoSmithKline Consumer today launched a new supplement for women buyers -- Women's Horlicks -- to strengthen its product portfolio in the health drink segment. -
Glenmark receives USFDA nod for Baddi plant
Fetched: January 28th, 2008, 12:05pm EST
Tags: [edit]
Glenmark Pharmaceuticals has received US Food & Drug Administration approval for its Baddi plant in Himachal Pradesh, which makes semi-solids (ointments and creams). -
Glenmark Pharma gets US nod for drug unit
Fetched: January 28th, 2008, 12:05pm EST
Tags: [edit]
Glenmark Pharma has received approval from the US Food and Drug Administration to sell ointments and creams in US. -
Govt suspends manufacturing licence of 4 drug firms
Fetched: January 27th, 2008, 8:32pm EST
Tags: [edit]
Union health ministry has suspended the manufacturing licence of four leading state-owned drug makers for violating the good manufacturing practices (GMP) they were bound to follow. -
Piramal executive kidnapping: Gangs identified
Fetched: January 27th, 2008, 2:56pm EST
Tags: [edit]
Madhya Pradesh Police on Sunday said that the gangs which kidnapped and held Nicholas Piramal senior executive Ashwini Bhatt and his driver as hostage have been identified. -
DST invites proposals for R&D
Fetched: January 27th, 2008, 2:56pm EST
Tags: [edit]
The Department of Science and Technology (DST) has invited research and development proposals from the pharmaceutical industry for generating intellectual property rights and development of products. -
Kidnapped Nicholas Piramal president rescued
Fetched: January 27th, 2008, 2:56pm EST
Tags: [edit]
Ashwini Bhatt and his driver, who were kidnapped on January 18, were traced by the Special Task Force of Madhya Pradesh Police along MP-UP border. Weekend platter
-
No word on Piramal executive still
Fetched: January 26th, 2008, 4:24am EST
Tags: [edit]
Fears that a top executive of pharma major Nicholas Piramal may have been abducted grew ominous when the police lodged a formal case of kidnapping, a week after he went missing. -
Cipla on firm ground in patent challenge
Fetched: January 25th, 2008, 3:43pm EST
Tags: [edit]
In what could strengthen Cipla's patent challenge against global major Gilead Science's patent application for its key HIV drug, Viread, the US Patent & Trademark office has rejected Viread patent application in the US. -
NPIL signs agreement with Spanish lab
Fetched: January 25th, 2008, 3:43pm EST
Tags: [edit]
Pharma major Nicholas Piramal India Ltd on Friday said it has signed an agreement with Spain based Pierre Fabre Laboratories for undertaking research in oncology. -
Dr Reddy's settles with Novartis on Exelon
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Drugmaker Dr Reddy's Laboratories Ltd said on Monday it had settled with Novartis on litigation related to a generic version of the Swiss firm's Exelon drug. -
Aurobindo gets US nod for cefdinir capsules
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Drug maker Aurobindo Pharma Ltd has received the US Food and Drug Administration approval to market its cefdinir antibiotic capsules in that country. -
Wockhardt gets US nod for Prozac generic
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Drug maker Wockhardt Ltd has received the US Food and Drug Administration approval to market fluoxetine hydrochloride capsules in multiple strengths. -
Ranbaxy Labs settles Imitrex patent litigation
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Ranbaxy Laboratories has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of Imitrex tablets. -
Pharma booming in tomorrow's world
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
For a change, the bottomline and the bottom rung match up. India’s emerging pharma frat knows how to cash in low and cash out to grow-they just innovate beyond boundaries. -
Govt plans pro-rata pricing of medicines
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
The government is all set to change the current way of fixing medicine prices, which gives companies the freedom to overcharge consumers. Take a chill pill
-
Nicholas Piramal undecided on strategic partner in R&D co
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
In the process of demerging its research and development segment into a new company, pharma company Nicholas and Piramal will decide in the next six months whether to have a partner in the new entity. -
Nicholas Piramal undecided on strategic partner in R&D company
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Pharma company Nicholas Piramal to decide on partner for its new entity to be demerged from itd R&D segment. -
Wockhardt to spin off R&D business
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Drug maker Wockhardt said on Friday it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. -
Ranbaxy to spin off research unit in 2nd half
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Ranbaxy Laboratories expects to spin off its research unit in the second half of the year, its chief executive said on Thursday. -
Biocon to partner US-based firm for developing cancer drug
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Biotech major Biocon Ltd on Thursday said it will enter into a partnership with a US-based biotechnology company, Iatrica, to develop drug for the treatment of cancer and infectious diseases. -
Ranbaxy Q4 net rises 4.4 %
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Ranbaxy Laboratories, India's top drug maker by sales, reported a 4.4 percent rise in quarterly net profit on Thursday, beating forecasts on strong sales of generic drugs in Western markets. -
Suven Life Sciences gets second US product patent
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Suven Life Sciences Ltd said on Wednesday it had received its second product patent from the US for a class of compounds being developed to treat neuro-degenerative disorders. -
Pro-rata pricing of medicines: An exercise in fatuity
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
The controllability of most of the 74 drugs, that were brought under price control more than a decade ago or even earlier, is questionable. -
DRL, Novartis smoke peace pipe on Alzheimer's drug
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Dr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastigmine tartrate till 2014. -
Ranbaxy settles generic sale dispute with GSK
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Ranbaxy Laboratories has reached an out-of-court settlement with UK’s pharma major GlaxoSmithKline to market generic copies of the latter’s $1 bn migraine headache drug Imitrex in the US. -
Aurobindo Pharma gets US FDA nod for Cefdinir Capsules
Fetched: January 25th, 2008, 12:10pm EST
Tags: [edit]
Pharmaceutical company Aurobindo Pharma ON mONDAY said it has received approval from the US Food and Drug Administration (FDA) to market its 300 mg Cefdinir Capsules. -
EU launches antitrust probe into pharmaceutical sector
Fetched: January 17th, 2008, 1:54am EST
Tags: pharmaceutical EU [edit]
The European Commission said on Wednesday that it had launched an antitrust probe into the pharmaceutical industry on concerns about uncompetitive behaviour in the sector. -
Dr Reddy's launches Supanac 50 mg tab in India
Fetched: January 17th, 2008, 1:54am EST
Tags: Dr.Reddy India Company [edit]
Dr Reddy’s Laboratories has launched Supanac-Diclofenac potassium immediate release 50 mg tablets in India. -
Ranbaxy enters into Chyawanprash segment
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories has entered into the Chyawanprash segment by launching Chyawan Active, a sugar-free product. -
No respite seen for pharma cos
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Investors are gearing up for a bitter pill from the pharma industry, as the third quarter ended December was marked by ever-rising competition and pricing pressure in US and European generic markets. -
Pharma cos unlikely to get sops for R&D
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug companies like Dr Reddy’s and Sun Pharma hoping for income tax sops for their stand alone research arms may be in for a disappointment. -
Blogs provide window to pharmaceutical industry in India
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting India's growth story
-
Marksans Pharma buys UK based Hale Group
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Marksans Pharma has acquired UK based pharma company Hale Group for an undisclosed amount. -
Sri Lankan ban on branded drugs will help India
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Indian pharmaceutical companies are likely to benefit from Sri Lanka's ban on the prescription of branded drugs, trade sources said. -
Marksans Pharma acquires 100% stake in Hale Group
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Marksans Pharma (UK), a subsidiary of Marksans Pharma, has entered into a definitive agreement to acquire 100 per cent share capital of Hale Group, the parent company of Bell, Sons & Co (Druggists). -
Drug cos face stricter checks on road to pricing freedom
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pharmaceutical companies will now have to face in-depth scientific scrutiny on how therapeutically useful are the ingredients that go into a medicine in order to charge a price for it. -
Gujarat can emarge as global pharmaceutical hub: KPMG
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Gujarat is poised to capture emerging opportuniteis to become a global pharmaceutical hub, international consultancy firm KPMG said in a report. -
Novartis to make a presentation to PMO on rural pharma
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Novartis will make a presentation to the PMO on selling over-the-counter medicines from post offices in rural areas to increase the industry's reach in villages. -
Novartis to make a presentation to PMO on rural pharma
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Global pharma major Novartis will make a presentation to the Prime Minister's Office on selling over-the-counter medicines from post offices in rural areas to increase the industry's reach in villages. -
Drug companies plan late-stage deals with MNCs
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In a distinct shift in their new drug development strategy, Indian pharma majors such as Dr Reddy’s Lab (DRL), Nicholas Piramal, Wockhardt and Sun Pharma are now looking at late-stage (Phase III) research collaboration with MNCs for their new chemical entity (NCE) pipeline. -
Japan's Daiichi to set up manufacturing, research unit
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing and research operation in the country. -
Panacea pre-qualified by WHO for combination vaccines
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Panacea Biotec has been pre-qualified by WHO for supplying innovative combination vaccines for pediatric immunization-EasyFour (DTP + Hib) and Ecovac (DTP + Hep B). -
Maneesh buys Smyle for Rs 53 cr
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In a bid to strengthen its presence in India’s OTC pharmaceutical mkt, Mumbai-based Maneesh Pharmaceuticals has acquired Kopran’s brand Smyle for Rs 53 cr. -
ICICI Ventures to buy Alved Pharma for up to Rs 30 cr
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Private equity (PE) major ICICI Ventures is acquiring Chennai-based standalone pharmaceutical and veterinary company Alved Pharma and Foods. -
Alembic buys bulk drug facility of Nirayu
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Alembic Ltd said on Thursday it has acquired the bulk drug manufacturing unit of Nirayu Pvt Ltd for a consideration of 175 million rupees. Nirayu is a part of the promoter group of Alembic. -
Arch Pharma to buy out promoters in Hyderabad company Avon
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Arch Pharmalabs, which recently acquired a 43% stake in Hyderabad-based pharma company Avon Organics, will raise its stake to a majority by buying out the 15% stake held by Avon’s original promoters if the current open offer fails, market sources said. -
Wockhardt launches cetirizine tablets in US
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug maker Wockhardt Ltd said late on Tuesday it had launched its cetirizine tablets in the US, following approval from the US Food and Drug Administration. -
It's quite patent for domestic pharma cos
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Contrary to Indian pharma companies’ fear that global pharma majors will dominate the Indian market in the post-patent era by launching patented products, domestic pharma companies have strengthened their hold in the Rs 35,000crore Indian drug market three years into the patent regime. -
Morepen lines up debt recast
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Morepen Laboratories, the loss-making, debt-laden pharma company, has struck a deal with lenders to restructure its debt and is also preparing to settle its outstanding fixed deposit with many depositors. -
India Ranbaxy gets FDA nod for allergy drug
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories Ltd India's top drug maker by sales, said on Monday it had received final approval from the US Food and Drug Administration to make and sell cetirizine hydrochloride tablets. -
Pfizer Ltd to get Rs 215 crore from licence transfer
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pfizer Ltd, the Indian unit of drug maker Pfizer Inc, said on Monday its board has approved transferring a licence to Johnson & Johnson Ltd for Rs 215 crore. -
Price reduction, rising Re triggers pharma slowdown
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Faced with price reduction and rupee appreciation, the growth of the Indian drug industry has slowed down this year. Gujarat Pharma industry celebrates
-
People turning to medicines to check the onset of diabetes
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Unable to squeeze in enough physical activity in their everyday life due to erratic work schedules, the young in India are increasingly turning to preventive medicines to check the onset of diabetes. -
Ranbaxy gets tentative US nod for dementia drug
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug maker Ranbaxy Laboratories Ltd has received tentative approval from the US Food and Drug Administration for galantamine hydrobromide oral solution, the regulator's Web site showed. -
Gujarat Pharma industry to celebrate 100 years of existence
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In order to commemorate 100 years of existence, Gujarat's pharmaceutical industry will converge on January 5, 2008 to celebrate this special milestone. -
Suven Life Sciences receives first US product patent
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Suven Life Sciences has received its first product patent from the US Patent Office. -
AstraZeneca denied patent for anti-ulcer drug
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The Indian patent office has turned down the company’s patent application for a new formulation of anti-ulcer drug Omeprazole. -
Teva’s protonix version sale in US to hit Sun
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In a development which may impact Sun Pharma’s hopes of a windfall by selling generic versions of Wyeth’s $2.5-billion drug Protonix. -
Elder Pharma in deal with Italian company
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Elder Pharmaceuticals on Monday said it has signed an in-licensing agreement with Gnosis of Italy. -
Alpa Labs in manufacturing deal with Wockhardt
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Alpa Laboratories Ltd said on Monday it has entered into a deal to manufacture products for Wockhardt Ltd. -
Dr. Reddy's gets tentative US OK for pantoprazole
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Dr. Reddy's Laboratories Ltd has received tentative approval from the US Food and Drug Administration for heartburn drug pantoprazole sodium in the extended release tablet format. -
DRL bets on India plan for German arm
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Dr Reddy’s Laboratories (DRL) aims to shift production of about a dozen top-selling products of its German arm Betapharm to India by July 2008 as it battles a supply crunch and price pressures in the European nation. -
Govt to rope in young minds to invent cheaper drugs
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The government has begun discussions with Sun Microsystems to set up web-management tools for an ‘open source’ drug discovery project. Day in Pics
-
Glenmark gets domestic patent for NCE
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In what is perhaps the first domestic patent for a new chemical entity (NCE) by an Indian company, drug research company Glenmark Pharmaceuticals has received a patent for its asthma molecule oglemilast from India’s patent office. -
'Pullout to hurt investor confidence'
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
This week, sources told ET that ICICI Venture and Citigroup Venture are in talks with Dr Reddy’s to pull out their investment in Perlecan on concerns over the viability of the molecules it is researching into. -
Agilent bags order from Orchid Chem
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Agilent Technology bags order to supply chromotography equipment from Orchid Chemicals and Pharmaceuticals Ltd. -
Aurobindo gets US nod for cefdinir antibiotic
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The US Food and Drug Administration have approved Aurobindo Pharma Ltd's antibiotic cefdinir in the oral suspension form, according to the regulator's Web site. -
Elder Pharma to sell Italy co's arthritis drug
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug firm Elder Pharmaceuticals Ltd said on Wednesday it has signed a deal to sell Italian biotech firm GNOSIS Spa's arthritic treatment SAMe in India. -
PEs may exit Dr Reddy's R&D unit
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
ICICI Venture Funds and Citigroup Venture Capital are likely to pull out their investment in Dr Reddy’s Laboratories’ drug research company, Perlecan Pharma, on concerns over the commercial viability of its experimental drugs. -
Kopran on the block
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The Mumbai-based Kopran is on the block. The promoters and Clearwater Capital Partners of Cyprus, who together hold 44% equity, are believed to be in talks with another Mumbai-based unlisted pharma company - Maneesh Pharmaceuticals, to sell their stake. -
Jubilant, Hikal drop out of race for Pfizer's Ireland unit
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
At least two Indian companies, Jubilant Organosys and Hikal Pharma, have dropped out of the race to acquire Pfizer's Ireland unit. However, other companies such as Nicholas Piramal and Dr Reddy's Laboratories (DRL) could still be in the fray. -
Govt brings out Indian Pharmacopoeia, 2007
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In an effort to control the quality of medicinal products, the government has brought out the Indian Pharmacopoeia, 2007, which lays down the standards for drugs produced or marketed in India. -
Bilcare builds on nanotech to counter drug counterfeiting
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pune-based pharma packaging company Bilcare Research has launched a product to help check the menace of counterfeit drugs. -
Pharma companies to scale up Romania operations
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Romania could soon become the hunting ground for Indian pharma companies who plan to strengthen their foothold in the European market. -
Govt to curb misuse of antibiotics in Ayurveda system
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The government was considering a proposal for a legilsation to curb misuse of antiboitics and anesthesia in the Ayurveda system, an official of AYUSH said on Sunday. -
SC issues notice to Pfizer on customs dept's plea
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The Supreme Court has sought a reply from drug firm Pfizer Ltd on a petition filed by customs department contending that it must pay 18 per cent additional duty on a chemical product imported as a poultry feed. -
Most Indian drug majors too in line for patent protection
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Out of the 8,000 drug patent applications in India filed between 1995 and 2004, about 40% are from Indian pharma companies. -
US drug makers turn to India, China for testing
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
US drug makers are making countries like India and China the testing ground for new medicines to shorten the time it takes for pharmaceutical products to enter the American market. -
Glenmark confirms Abbott suit against Tarka generic
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Glenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to prevent Glenmark from proceeding with the commercialisation of Trandolapril. -
Sanofi, Abbott file lawsuit against Glenmark
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Sanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hypertension drug in the US. -
Glenmark soars on likely deal of $150 mn
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Market participants expect payout to Glenmark from such a deal would include upfront and milestone payments and royalties on sales. -
Dabur's H&B Stores ties up with 3 foreign labs for pvt label
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Dabur India's health and beauty retail subsidiary H&B Stores has tied up with labs in Italy, the UK and Thailand. -
Ranbaxy to share Fortis brand name with Dutch firm
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
A major hurdle for the Indian entry of Belgian-Dutch financial group Fortis has at last been cleared. -
HIV drugs to cost more as cos rush for patents
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
HIV treatment in India could get costlier as global pharma cos have started securing patents for drugs used to treat AIDS and related diseases. -
Abbott files patent suit against Zydus Cadila in US court
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
US-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US. -
SC issues notice to Pfizer on customs dept's plea
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The Supreme Court today sought a reply from Pfizer Ltd on a petition filed by the customs department alleging the firm must pay 18 per cent additional duty on a chemical product imported as a poultry feed. -
SC notice to Aventis Pharma on Novartis plea
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The Supreme Court today issued notice to Aventis Pharma Ltd on a petition filed by Novartis Vaccines & Diagnostics Inc seeking reference of a dispute over marketing of anti-rabies vaccine for arbitration. -
NPIL gets product patent from US Patent & Trademark Office
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Nicholas Piramal India on Monday said the US Patent and Trademark office has granted product patent to the company for compounds being developed for cancer treatment. -
Ranbaxy gets USFDA nod to mkt generic copy of Aricept
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market donepezil hydrochloride. -
Taro to vote on merger with Sun in Q1
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Taro Pharmaceutical Industries’ crucial shareholder meeting to vote on the proposed merger with India’s Sun Pharma will be held in the first quarter of 2008. -
PHD Chamber asks for more weighted deduction on pharma R&D
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Industry body PHD Chamber has urged the government to raise the weighted deduction on research and development expenses by pharma sector to 200 per cent from the current 150 per cent. -
Ranbaxy gets tentative FDA nod for Alzheimer's medicine
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories Ltd has received tentative approval from the US Food and Drug Administration for donepezil hydrochloride tablets, the regulator's Web site showed. -
Ranbaxy gets USFDA nod to market two ARV drugs
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories has received US Food and Drug Administration’s (USFDA) approval to manufacture and market two paediatric anti-retroviral (ARV) drugs, Coviro-LS kid and Coviro-LS kid DS, in the US. -
Sun settles patent row with Novartis
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Sun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute over the Swiss drug major’s Alzheimer’s drug Exelon, the Indian company said on Thursday. -
GSK drops claims on two AIDS medicines
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
In a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent applications of two anti-AIDS medicines in India. -
Sun, Novartis settle Exelon drug dispute
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Sun Pharmaceutical has reached an out-of-court settlement with Novartis in the US with regard to a patent dispute over the Swiss drug major Novartis’ Alzheimer’s drug Exelon, the Indian company said on Thursday. -
Glenmark Pharma eyes Indonesian co
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Glenmark Pharmaceuticals plans to acquire a distribution and marketing company in Indonesia, in a bid to increase its foothold in Asia’s emerging markets. -
Dabur launches ayurvedic medicine for breathlessness
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Home grown FMCG major Dabur India Ltd on Wednesday announced it has launched 'Shwaasamrit' - an Ayurvedic medicine for combating breathlessness. -
Now, you may buy drugs from post office
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Over-the-counter (OTC) drugs may soon be available in post offices across the country if an initiative by the drug makers and the government fructify. -
DSM Anti Infectives, Arch in strategic pact
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Global multispeciality chemical company, DSM has entered into a manufacturing agreement with pharma major Arch Pharmalabs for manufacturing of generic Active Pharmaceutical Ingredients (APIs). -
Diabetes drug may increase chances of osteoporosis
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures. -
3M in talks to license drug delivery tech
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
US-Based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies. -
Pfizer considers outsourcing manufacturing to India, China
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia. -
CRAMS cos buck pharma trend, give good returns
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The pharma sector may have underperformed the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns. -
PEs take fancy to pharma cos with outsourcing deals
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Small and mid-size pharma companies focused on outsourcing seem to have caught the attention of investors, if the recent investments by private equity (PE) players in the sector are any indication. -
Tata drug development centre opened in Bangalore
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The $22-billion Tata group has opened a drug development centre here Thursday for high-end research in pharmaceuticals. -
New pharma min to track price dodgers
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug makers may not be able to avoid price control by making use of the division of powers between different ministries for long. -
Glenmark plans Nigeria expansion; expects $1.3 mn sales
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Glenmark Pharmaceuticals plans to expand its presence in the Nigerian market. Its subsidiary, Glenmark Pharmaceuticals Nigeria, having started operations in April this year, expects sales of $1.3 million by the end of this fiscal. -
Citi Venture picks up 30% in Unimark
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
US-based PE fund Citi Venture Capital has picked up 30% stake in Mumbai-based bulk drug maker Unimark Remedies for Rs 113 crore. -
Suven gets European Patent nod for two therapeutic agents
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Suven Life Sciences on Tuesday said the European Patent Office (EPO) has granted patents to two of its therapeutic agents which are used in the treatment of neurodegenerative disorders. -
Hospital-run pharmacies come under govt scrutiny
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The finance ministry is working with the commerce ministry to clarify the legal status of such pharmacies. First aid for burn and eye injury
-
Towards better medicines: Need for incentives to innovate
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ever since the passing of the Third amendment to the Patents Act, increasingly strident voices have been raised against pharmaceutical patents. -
Elder to launch 8 drugs in CIS, European foray
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Elder Pharma to foray in Commonwealth of Independent States and European market by launching eight drugs in the women healthcare, woundcare and nutraceutical segment. -
DRL identifies anti-inflammatory drug for pre-clinical trial
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pharmaceuticals major Dr Reddy's Laboratories and its UK-based partner Argenta Discovery on Monday said they have selected the first candidate drug, an anti-inflammatory molecule, for treating chronic respiratory disease. -
Venus Remedies files patent for meningitis formula
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Pharmaceutical company Venus Remedies Ltd says it has filed for patent protection of its formula for treating Meningitis in 48 countries. -
Zydus bets on off-patent generics
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The company plans to launch 100 drugs in US & Europe over the next five years. -
NPPA seeks more consumer feedback to boost checks
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The National Pharmaceutical Pricing Authority (NPPA) will take consumers’ feedback in a bid to improve detection of drugs that are being over charged for or are sold without price approval in India. -
Drug regulator in strict enforcement mode
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Drug majors like Ranbaxy, Dr Reddy’s, GlaxoSmithKline, Cadila Pharma and Lupin may have a lesson to learn from the trouble they have landed themselves in recently with regard to pricing of some of their key pharmaceutical brands. -
Serum puts off plans to go public
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Serum Institute of India, the Rs 1,000-crore vaccine manufacturer, has put off its plans to go public for another year. -
Strides LatAm business to help Aspen grow globally
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Aspen Pharmacare is no newcomer to India. The South African generic major sources material from India for its drugs and has joint-ventures with Matrix Laboratories. -
Only a fraction of Indian drugs is substandard
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
The scare over substandard drugs flooding the market is akin to making a mountain out of a molehill, says a nation-wide study funded by the World Health Organization. -
Ranbaxy in out-of-court deal for innovator drug
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories has reached an out-of-court settlement to market the generic copy of an innovator drug worth over $1 billion in the US. -
Spurious drugs estimated to be 3.1%
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
As various organisations claimed that the percentage of spurious drugs in the country was more than 30 %, the Centre said the extent of suspected counterfeiting was only about 3.1%. -
Ranbaxy receives nod for Tamsulosin Hydrochloride capsules in Canada
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Ranbaxy Laboratories has received approval to manufacture and market Tamsulosin Hydrochloride capsules in 0.4 mg strength from Health Canada, Therapeutic Products Directorate. -
DCGI likely to invoke special provisions to ban 294 drugs
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Faced with resistance from drug makers and legal reversals, the Drug Controller General of India (DCGI) will use all means within his command to ban the contentious 294 fixed dose combination (FDC) drugs from the retail market. -
Sops for pharma cos may be extended to 2015
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Consumers can hope for some reduction in the prices of drugs across the board and particularly in the case of cancer and HIV/AIDs drugs soon. -
Dabur to set up subsidiaries in Italy, Germany
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
Dabur Pharma, a Delhi-based specialty company focused on anti-cancer products, is planning to set up subsidiaries in Italy and Germany to expand its foothold in Europe. -
Strides, Aspen ink four JVs to strengthen niche arms
Fetched: January 14th, 2008, 12:32pm EST
Tags: [edit]
It is raining deals at Bangalore-based mid-sized pharma player Strides Arcolab.